Cargando…
Epidemiology and prevention of respiratory syncytial virus infections in children in Italy
Respiratory syncytial virus (RSV) is the leading global cause of respiratory infections in infants and the second most frequent cause of death during the first year of life. This highly contagious seasonal virus is responsible for approximately 3 million hospitalizations and 120,000 deaths annually...
Autores principales: | Azzari, Chiara, Baraldi, Eugenio, Bonanni, Paolo, Bozzola, Elena, Coscia, Alessandra, Lanari, Marcello, Manzoni, Paolo, Mazzone, Teresa, Sandri, Fabrizio, Checcucci Lisi, Giovanni, Parisi, Salvatore, Piacentini, Giorgio, Mosca, Fabio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487331/ https://www.ncbi.nlm.nih.gov/pubmed/34600591 http://dx.doi.org/10.1186/s13052-021-01148-8 |
Ejemplares similares
-
Revised recommendations concerning palivizumab prophylaxis for respiratory syncytial virus (RSV)
por: Bollani, Lina, et al.
Publicado: (2015) -
Invasive meningococcal disease in Italy: from analysis of national data to an evidence-based vaccination strategy
por: IGIDBASHIAN, S., et al.
Publicado: (2020) -
A new cost-utility analysis assessing risk factor-guided prophylaxis with palivizumab for the prevention of severe respiratory syncytial virus infection in Italian infants born at 29–35 weeks’ gestational age
por: Keary, Ian P., et al.
Publicado: (2023) -
RSV disease in infants and young children: Can we see a brighter future?
por: Baraldi, Eugenio, et al.
Publicado: (2022) -
Respiratory Syncytial Virus Resurgence in Italy: The Need to Protect All Neonates and Young Infants
por: Bozzola, Elena
Publicado: (2021)